Group items tagged

The report provides insights into two therapeutic indications in ophthalmology in top eight markets of the US, the UK, France, Germany, Italy, Spain, Japan and Canada.

"Analytical Tool - Breast Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in breast cancer R&D and business development.

"Analytical Tool - Pancreatic Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in pancreatic cancer R&D and business development. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work.

This report vitiligo - pipeline review, h2 2013, provides information on the therapeutic development for vitiligo, complete with latest updates, and special features on late-stage and discontinued projects.

"Analytical Tool - Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody drug development for the treatment of cancer.

"Analytical Tool: Lymphoma" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in lymphoma R&D and business development.

"Analytical Tool - Colorectal Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in colorectal cancer R&D and business development.

"Analytical Tool - Prostate Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in prostate cancer R&D and business development.

This report waldenstrom macroglobulinemia pipeline review 2013 provides information on the therapeutic development for waldenstrom macroglobulinemia, complete with latest updates, and special features on late-stage and discontinued projects.

This report provides information on the therapeutic development for Systemic Sclerosis (Scleroderma), complete with latest updates, and special features on late-stage and discontinued projects.

Valued at USD 26.3 billion in 2013 major growth stimulators in the Australian defense industry include military modernization, counter terrorism activities, and participation in peacekeeping missions.

Although the pace of growth is declining, flavored beers have recorded one of the highest growth rates among all beer segments and increased by more than 7% in volume. An increase in excise duty from January 2013 was widely expected to impact the beer markets development. Larger brewers in particular will be affected and will be forced to pass any increases on to the consumer. Growth of metal cans continued in 2012, although at a lower level than 2011, while the 50cl can was particularly popular with an increasing number of brands using this pack type.

Indian companies are taking center stage in Complex Generics at US and EU markets. In Bio-similars, Indian companies will have perhaps the largest basket aimed at Emerging Countries in 2014-16 and later for Developed countries.

This report provides comprehensive information on the therapeutic development for male infertility, complete with comparative analysis at various stages, therapeutics assessment by drug target.

This report provides comprehensive information on the therapeutic development for Brain Cancer, complete with comparative analysis at various stages.

This report provides comprehensive information on the therapeutic development for Arthritis, complete with comparative analysis at various stages.

This report provides comprehensive information on the therapeutic development for Type 2 Diabetes, complete with comparative analysis at various stages.